mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |